<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Conversational no-code and multi-agentic disease module identification and drug repurposing prediction with ChatDRex - Health AI Hub</title>
    <meta name="description" content="ChatDRex is a novel conversational multi-agent system designed to simplify complex bioinformatics analyses for network-based drug repurposing and disease module">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Conversational no-code and multi-agentic disease module identification and drug repurposing prediction with ChatDRex</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.21438v1" target="_blank">2511.21438v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Simon S√ºwer, Kester Bagemihl, Sylvie Baier, Lucia Dicunta, Markus List, Jan Baumbach, Andreas Maier, Fernando M. Delgado-Chaves
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI, cs.MA
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.21438v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.21438v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">ChatDRex is a novel conversational multi-agent system designed to simplify complex bioinformatics analyses for network-based drug repurposing and disease module identification. It provides natural language access to an extensive biomedical knowledge graph (NeDRex), enabling physicians and researchers without computer science expertise to predict drug candidates and accelerate therapeutic discovery. The system aims to democratize access to advanced bioinformatics, fostering hypothesis generation and ultimately advancing personalized medicine and translational research.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This technology is highly relevant to medicine and health as it streamlines the identification of new therapeutic uses for existing drugs, a time- and cost-efficient alternative to traditional drug development. By making complex bioinformatics accessible to medical professionals, it can significantly accelerate the discovery of treatments and tailor therapies to specific diseases.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>ChatDRex is a conversational, multi-agent AI system that uses natural language processing to enable physicians and clinical experts to perform complex bioinformatic analyses for network-based drug repurposing prediction and disease module identification. It democratizes access to advanced bioinformatics tools for accelerating drug discovery, identifying novel therapies, and advancing personalized medicine.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical challenge of in silico drug repurposing, which is hampered by fragmented specialized tools, heterogeneous data landscapes, and the need for multi-disciplinary expertise.</li>
                    
                    <li>Introduces ChatDRex, a conversation-based, multi-agent system built upon the integrated systems medicine knowledge graph, NeDRex, to facilitate complex bioinformatic analyses.</li>
                    
                    <li>Provides natural language access to its extensive biomedical knowledge graph and integrates specialized bioinformatics agents for network analysis, drug repurposing prediction, and functional coherence evaluation.</li>
                    
                    <li>Incorporates additional agents for literature mining and for discussing scientific results, complemented by a flexible multi-agent design for tasks like query routing, data retrieval, algorithm execution, and result visualization.</li>
                    
                    <li>Features a dedicated reasoning module designed to keep the user informed and involved throughout the analysis process, including mechanisms for hallucination detection.</li>
                    
                    <li>Democratizes access to bioinformatics by enabling physicians and researchers without programming expertise to control and execute sophisticated analyses using natural language commands.</li>
                    
                    <li>Aims to accelerate the discovery of novel therapies, advance personalized medicine, and foster translational research by empowering clinical experts to generate and explore drug repurposing hypotheses efficiently.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>ChatDRex operates as a conversation-based, multi-agent system leveraging the integrated systems medicine knowledge graph NeDRex. Its methodology involves natural language processing for user input, specialized agents for query routing, data retrieval from the KG, execution of bioinformatics algorithms (e.g., network analysis for disease module identification and drug repurposing prediction), functional coherence evaluation for in silico validation, literature mining, and result visualization and scientific discussion. A reasoning module is integrated to maintain user context and detect potential hallucinations.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary finding is the successful development and conceptualization of ChatDRex as a functional system that democratizes access to complex bioinformatics for drug repurposing. It demonstrates the feasibility of empowering non-computer science experts, such as clinicians and medical researchers, to effectively generate hypotheses and explore drug repurposing opportunities by interacting with integrated biomedical knowledge and computational tools through natural language.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>ChatDRex has the potential to significantly impact clinical practice by accelerating drug repurposing, leading to faster availability of new treatment options for patients. It empowers clinicians to directly participate in hypothesis generation for novel therapies, fostering personalized medicine approaches by identifying context-specific drug candidates. This system effectively bridges the gap between complex bioinformatics and clinical application, advancing translational research by generating clinically relevant insights.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the ChatDRex system.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions, but rather emphasizes the current and projected impact of the system in accelerating drug discovery and advancing personalized medicine and translational research.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Clinical medicine</span>
                    
                    <span class="tag">Drug discovery</span>
                    
                    <span class="tag">Systems medicine</span>
                    
                    <span class="tag">Biomedical research</span>
                    
                    <span class="tag">Personalized healthcare</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Drug repurposing</span>
                    
                    <span class="tag tag-keyword">Multi-agent system</span>
                    
                    <span class="tag tag-keyword">Natural language processing</span>
                    
                    <span class="tag tag-keyword">Bioinformatics</span>
                    
                    <span class="tag tag-keyword">Knowledge graph</span>
                    
                    <span class="tag tag-keyword">Personalized medicine</span>
                    
                    <span class="tag tag-keyword">Translational research</span>
                    
                    <span class="tag tag-keyword">Disease modules</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Repurposing approved drugs offers a time-efficient and cost-effective alternative to traditional drug development. However, in silico prediction of repurposing candidates is challenging and requires the effective collaboration of specialists in various fields, including pharmacology, medicine, biology, and bioinformatics. Fragmented, specialized algorithms and tools often address only narrow aspects of the overall problem, and heterogeneous, unstructured data landscapes require specialized users to be involved. Hence, these data services do not integrate smoothly across workflows. With ChatDRex, we present a conversation-based, multi-agent system that facilitates the execution of complex bioinformatic analyses aiming for network-based drug repurposing prediction. It builds on the integrated systems medicine knowledge graph NeDRex. ChatDRex provides natural language access to its extensive biomedical KG and integrates bioinformatics agents for network analysis and drug repurposing, complemented by agents for functional coherence evaluation for in silico validation, as well as agents for literature mining and for discussing the obtained results in a scientific context. Its flexible multi-agent design assigns specific tasks to specialized agents, including query routing, data retrieval, algorithm execution, and result visualization. A dedicated reasoning module keeps the user in the loop and allows for hallucination detection. By enabling physicians and researchers without computer science expertise to control complex analyses in natural language, ChatDRex democratizes access to bioinformatics as an important resource for drug repurposing. It enables clinical experts to generate hypotheses and explore drug repurposing opportunities, ultimately accelerating the discovery of novel therapies and advancing personalized medicine and translational research.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>